Publication: EVALUATION OF THE EFFICACY AND SAFETY OF THE SARS-COV-2 VACCINE IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES TREATED WITH BIOLOGICAL THERAPY.
Loading...
Identifiers
Date
2022-06-01
Authors
Calvo Gutierrez, J.
Lopez-Medina, C.
Abalos-Aguilera, M. C.
Perez Jimenez, A. B.
Ruiz-Vilchez, D.
Pilar, F. U.
Ortega Castro, R.
Escudero Contreras, A.
Collantes Estevez, E.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Bmj publishing group
Metrics
Export
Abstract
In the current situation of the SARS-CoV-2 pandemic, the Spanish Society of Rheumatology recommends vaccination of patients with chronic inflammatory diseases (CID) under treatment with biological DMARDs (bDMARDs). However, the data regarding the generation of protective antibody titers after mRNA vaccines in patients with CID is limited.
Description
MeSH Terms
SARS-CoV-2
mRNA vaccines
Pandemics
Rheumatology
Undertreatment
Vaccination
Antirheumatic agents
mRNA vaccines
Pandemics
Rheumatology
Undertreatment
Vaccination
Antirheumatic agents
DeCS Terms
Antirreumáticos
Pandemias
Reumatología
Tratamiento insuficiente
Vacunas de ARNm
Pandemias
Reumatología
Tratamiento insuficiente
Vacunas de ARNm
CIE Terms
Keywords
Citation
Gutierrez JC, López-Medina C, Ábalos-Aguilera MC, Jiménez ABP, Ruíz-Vilchez D, Pilar FU, et al. AB1149 EVALUATION OF THE EFFICACY AND SAFETY OF THE SARS-COV-2 VACCINE IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES TREATED WITH BIOLOGICAL THERAPY. Annals Of The Rheumatic Diseases [Internet]. 23 de mayo de 2022;81(Suppl 1):1691.2-1692.